SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-074565
Filing Date
2024-06-25
Accepted
2024-06-25 08:00:18
Documents
25
Period of Report
2024-06-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2418076d1_8k.htm   iXBRL 8-K 52543
2 EXHIBIT 4.1 tm2418076d1_ex4-1.htm EX-4.1 99635
3 EXHIBIT 4.2 tm2418076d1_ex4-2.htm EX-4.2 97074
4 EXHIBIT 4.3 tm2418076d1_ex4-3.htm EX-4.3 98477
5 EXHIBIT 4.4 tm2418076d1_ex4-4.htm EX-4.4 98195
6 EXHIBIT 5.1 tm2418076d1_ex5-1.htm EX-5.1 12860
7 EXHIBIT 10.1 tm2418076d1_ex10-1.htm EX-10.1 250499
8 EXHIBIT 10.2 tm2418076d1_ex10-2.htm EX-10.2 267351
9 EXHIBIT 10.3 tm2418076d1_ex10-3.htm EX-10.3 98155
10 EXHIBIT 99.1 tm2418076d1_ex99-1.htm EX-99.1 15606
14 GRAPHIC tm2418076d1_8kimg001.jpg GRAPHIC 21478
15 GRAPHIC tm2418076d1_ex5-1img001.jpg GRAPHIC 11418
16 GRAPHIC tm2418076d1_ex5-1img002.jpg GRAPHIC 8496
  Complete submission text file 0001104659-24-074565.txt   1619871

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA nrbo-20240623.xsd EX-101.SCH 3030
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nrbo-20240623_lab.xml EX-101.LAB 34240
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nrbo-20240623_pre.xml EX-101.PRE 22369
28 EXTRACTED XBRL INSTANCE DOCUMENT tm2418076d1_8k_htm.xml XML 3690
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 241066179
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)